Market Overview

Boston Scientific Corporation Sees Q1 Sales $1.74B-1.82B vs $1.79B Est, Sees FY13 Sales $7.05B-7.35B vs $7.12B Est.

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→